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Abstract
In recent years, functional foods and bioactive components in foods have drawn a lot of attention as 
well as interest of food scientists, nutritionists, health professionals, and consumers. The advent of this 
new food category has been facilitated by increasing scientific knowledge about the metabolic and 
genomic effects of diet and specific dietary components on human health. The relationship between 
health and diet is well known and it is a main key for prevention of variety of diseases. Milk is con-
sidered as a very good source of bioactive components and it has been known to contain macro- as 
well as micronutrients of high nutritional and therapeutic value. Also, bioactive components have been 
exploited from milk and dairy products for application in functional foods and for potential pharmaceu-
tical use. Biologically active compounds guard neonates and adults against pathogens and illnesses. 
Some major bioactive components of milk are derived from caseins, whey proteins, lipids, lactoferrine, 
vitamins, immunoglobulins and growth factors. The aim of this paper was to provide an overview and 
explain the health effects of already known and recently detected bioactive components derived from 
bovine milk on humans. 
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Introduction
Milk and milk products presents a good source 
of nutritional components like valuable proteins, li-
pids, lactose as well as micro- and macronutrients. 
It is well known that milk presents the nature’s 
most complete food for growth and development 
of mammals. In recent years, there has been an in-
creasing interest of consumers in functional food, 
which not only meets the primary function, but also 
has some benefits on human health. Functional 
food has emerged as a new approach to improve 
human nutrition and health in the environment 
where lifestyle diseases and aging populations are 
considered as a threat to the well-being of the so-
ciety. Accordingly, the dairy industry has achieved 
a leading role in the development of functional 
foods and has already commercialized products 
that boost, for example, the immune system; re-
duce elevated blood pressure; combat gastrointes-
tinal infections; help to control body weight; and 
prevent osteoporosis (Pihlanto, 2011). In addition 
to naturally present components (proteins, lipids, 
lactose and micro- and macronutrients) in milk, 
there are variety of other components that occur 
during milk processing or intestinal digestion (en-
zyme hydrolysis) and are called bioactive compo-
nents since they provide various health benefits 
(Nongonierma and FitzGerald, 2015). The term 
bioactive components refers to compounds either 
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naturally existing in food or the ones formed and/
or formulated during food processing that may 
have physiological and biochemical functions when 
consumed by humans. Food scientists have been 
exploiting bioactive components of milk and dairy 
products for application in functional foods and for 
potential pharmaceutical use. Milk is often consid-
ered as a functional food since it contains varieties 
of different bioactive components. Some bioactive 
components in milk are primary present in milk like 
growth factors (epidermal growth factor, neuronal 
growth factors, vascular endothelial growth fac-
tors, erythropoietin, growth regulating factors) and 
immune-related factors (immune cells, cytokines, 
chemokines) (Giacometti and Buretić-Tom-
ljanović, 2017; Bal lard and Morrow, 2013). 
Figure 1 presents an overview of bioactive compo-
nents derived from milk.
overview of currently known bioactive components 
from milk, either naturally present or obtained af-
ter digestion and/or after milk processing. Also, a 
review of some most recently detected bioactive 
components has been given.
Bioactive peptides
Bioactive peptides can be derived from milk 
proteins, either casein or whey proteins. Produc-
tion of bioactive peptides offers ingredients for a 
low-cost production and positive nutritional image 
associated to fermented milk. Generally, bioactive 
peptides can be produced by three main ways: by 
enzymatic hydrolysis with digestive enzymes; by 
fermentation of milk with proteolytic starter cul-
tures; and by proteolysis with enzymes derived 
from microorganisms or plants. Also, some studies 
suggest the combination of these three mentioned 
models to be effective in generating functional bi-
oactive peptides (Egger et al., 2017; Mann et al., 
2019). Other animal or plant proteins are also a 
source of bioactive peptides, but milk proteins are 
the most important and the most abundant source, 
especially regarding the fact that milk is cost effec-
tive and is consumed on everyday basis. Bioactive 
peptides act as signalling molecules and thus play 
an important role in numerous physiological func-
tions and pathogeneses (biological mechanism that 
leads to diseased state). When bioactive peptide is 
formed from maternal protein, one of the possible 
ways to act is being a regulatory compound with 
hormone-like activity (Mann et al., 2019). Some 
of physiological effects on human functions that 
bioactive peptides possess are effect on immune, 
cardiovascular, nervous and gastrointestinal sys-
tem (Figure 2).
Having a role in human health by action on 
human functions, bioactive peptides have mul-
tiply beneficial effects like hypocholesterolemic, 
antioxidative, antithrombotic, antimicrobial, im-
munomodulatory, mineral binding, antihyperten-
sive, antimicrobial and opioid antagonist/agonist 
(Biadala and Konieczny, 2018; Park and Nam, 
2015). Bioactive peptides usually contain 3-20 
amino acids residues per molecule. The activity of 
bioactive peptides has been related to the specific 
amino acid composition and sequence. Bioactive 
FigURe 1. Schematic review of major bioactive components in milk
The most abundant and the most researched 
bioactive components are related to milk proteins 
(casein and whey proteins) and arise during their 
digestion or production of dairy products. Those are 
called bioactive peptides and refer to small frag-
ments obtained from the maternal protein. They 
have biological function and are regarded as highly 
prominent ingredients for health promoting, func-
tional foods or pharmaceutical preparations. Apart 
from the conventional knowledge, recent research 
is being carried out to investigate the “hidden” prop-
erties of milk, respectively the component that is 
present in milk and also possess a biological func-
tion in human organism, miRNA (microRNA) (Rani 
et al., 2017). The increasing number of studies that 
have been published over the past few years con-
cerning bioactive components in foods, mostly in 
milk and dairy products, suggest that there is an 
increasing interest in their identification and appli-
cation in both, food and industry. Thus, the main 
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FigURe 2. Physiological effect of bioactive peptides formed from milk proteins on human functions (modified according to 
Mohanty et al., 2016)
peptides that possess the same activity usually 
have similar structural properties. Table 1 presents 
the main activities of bioactive peptides and their 
specific structural properties. In particular, the block 
of N-terminal group or/and of C-terminal group, as 
well as the phosphorylation of amino acids serine, 
threonine and tyrosine, prevent the peptide hydrol-
ysis by digestive proteases and thus, give them a 
better opportunity to improve penetration of bio-
logical barriers. In general, bioavailability of bioac-
tive peptides in human body depends on proteases 
peptiDes FoRmeD 

















Digestive system Immune system
present in gastrointestinal tract, elimination by re-
nal function and ability to cross the cell membrane. 
Modification of the N- and C-amino acid terminals 
protect the peptides from aminopeptidase and car-
boxypeptidase (Gianfranceschi et al., 2018; Mo-
hanti et al., 2016).
tABle 1. The main bioactive peptides, their activities and structural properties (modified according to Pihlanto, 2011) 
Activity Structural characteristics
Opioid
Tyrosine at N-terminus, connected with another aromatic residue (Phe or Tyr), 
in the 3rd or 4th position
ACE inhibitory
(Antihypertensive)
Hydrophobic amino acids or positive charge of Lys or Arg on the C-terminus
Antithrombotic
Ile108, Lys112 and Asp115 residues of casoplatelins (peptides derived from 
κ-casein)
Antioxidant High amounts of His and hydrophobic amino acids
Hypocholesterolemic
Low ratios of Met-Gly and Lys-Arg in proteins. High amount of hydrophobic  
amino acids
Antimicrobial Positively charged residues and hydrophobic region that contains Trp
Many bioactive peptides derived from milk can 
excrete two or more bioactive functions and thus 
may beneficially influence human health. Table 
2 provides a review of the most researched and 
abundant bioactive peptides.
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tABle 2. Some bioactive peptide sequences and their functions released from caseins and whey proteins  
(modified according to Egger and Ménard, 2017)
Sequence Name Fragment Effect









































Recently, a group of scientists (Nielsen et al., 
2017) realized that over the past decade there has 
been an increasing number of identified bioactive 
peptides with their proven biological functions de-
rived milk proteins. They formed a unique database 
(http://mbpdb.nws.oregonstate.edu) comprising 
the currently available literature and database is 
regularly updated (last time updated, May 2018). 
They identified 258 original research articles that 
describe the biological activity of certain peptide. 
The database consists of 944 bioactive peptides 
originated from ten different species (76 % from 
cow milk). Peptides included in database involve 
177 peptides that manifest antimicrobial proper-
ties and 323 peptides with ACE-inhibitory activity. 
Rest of the peptides show antioxidant, opioid, an-
ti-cancer, anti-inflammatory and immunomodula-
tory properties. The formed database allows iden-
tification of similar peptides with a high potential 
for function and guide further therapeutic discovery 
(Nielsen et al., 2017). 
Influence of bioactive peptides on human 
health
Heart diseases and high blood pressure are a 
worldwide health problem, and there is a lack of 
effective pharmaceutical medicaments. Bioactive 
peptides may be one of the crucial ingredients that 
could be added to different food systems and by 
that significantly contribute to reduction of a global 
problem. Products fortified with bioactive peptides 
are already present on the market. Some products 
with health claim to reduce blood pressure can be 
found on the market under brand names Calpis 
(Sour milk enriched with VPP, IPP; Calpis C., Japan) 
and Evolus (Fermented milk drink, bioactive pep-
tides: VPP, IPP; Valio Oy, Finland). In addition, prod-
uct labelled with health claim that reduces stress 
is as well present on the market under the brand 
name Prodiet F200 (Flavoured milk drink, bioactive 
peptide: YLGYLEQLLR; ingredia, France) (Pihlanto, 
2011). 
Bioactive peptides are continuously being iden-
tified from either casein or whey protein hydro-
lysates. One of the novel bioactive peptide that has 
been identified is angiotensin I-converting enzyme 
(ACE)-inhibitory (ACEI) peptide, with amino acid se-
quence NMAINPSKENLCSTFCK. This peptide has 
been derived by tryptic hydrolysis from the αs2-ca-
sein originating in fragment residues from the 25th 
to the 41st amino acid, and was subsequently iden-
tified by the UPLC-ESI-Q-TOF-MS/MS method. The 
IC50 (half maximal inhibitory concentration) value 
of the peptide was determined by a HPLC method, 
and amounted for 129.07 μM. Tu et al. (2018) ap-
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plied in their research a Lineweaver-Burk plot and 
showed that this peptide acted as a mixed-type 
inhibitor against ACE, which might be attributed 
to the peptide being susceptible to degradation by 
ACE, indicating that the mixed-type inhibition could 
partly be a result of the newly generated peptide 
fragments. Also, they evaluated physicochemical 
characteristics and the secondary structure by cir-
cular dichroism analysis and online prediction soft-
ware (Expasy, PepDraw, and ProtParam) to identify 
the basic characteristics of this peptide. Moreover, 
a molecular docking was simulated by Discov-
ery Studio 2017 R2 software to provide potential 
mechanisms underlying the ACEI activity of the 
peptides (Tu et al., 2018).
About 50 % of milk solids pass into whey during 
the cheese or casein production, among which are 
the whey proteins (20 % of total protein), most of 
the lactose, minerals, and water soluble vitamins. 
Whey presents a rich and heterogeneous mixture 
of secreted proteins with wide-ranging chemical, 
physical and functional properties (Lisak Jakop-
ović et al., 2016). Proteins lagged in whey include 
α-lactalbumin (α-La), β-lactoglobulin (β-Lg), lacto-
ferrin (Lf), lactoperoxidase, immunoglobulins, gly-
comacropeptide (GMP), proteose peptone, and a 
various growth factors (Lisak Jakopović et al., 
2019; Lisak  et al., 2013). These proteins have 
been involved in numerous biological functions, and 
show anticancer activity as well as influence to di-
gestive functions. Whey proteins present an essen-
tial source of amino acids, but they have also been 
recognized and classified as dietary proteins which 
exert many other functions in vivo by means of bi-
ologically active peptides (Mann et al., 2019). Milk 
fermentation using lactic acid bacteria (LAB) or 
their proteinases has been described as a strategy 
to release ACE-inhibitory peptides from milk pro-
teins by many authors (Hayes et al., 2006; Mann 
et al., 2018). The most often researched bioactive 
peptides that excrete ACE-inhibitory properties are 
Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP). Those pep-
tides can be derived from casein by fermentation 
with Lactobacillus helveticus and Saccharomyces 
cerevisiae, respectively, and are found in the com-
mercial sour milk product Calpis (Calpis, Co. Ltd., 
Tokyo). The antihypertensive effect of Calpis was 
shown by Yamamoto et al. (1994) and Hata et 
al. (1996). Results showed that Calpis decrease 
a systolic blood pressure for 17.7 mmHg by con-
sumption of 5 mL/kg body weight of Calpis sour 
milk drink over an 8-hour period in spontaneously 
hypertensive rats (Yamamoto et al., 1994). Like-
wise, a significant reduction in blood pressure was 
observed in mildly hypertensive patients who took 
orally 95 mL of Calpis over an 8-week period (Hata 
et al., 1996). Particularly, it has been shown that 
non-hydrolysed β-Lg has a very low ACE-inhibito-
ry activity but its hydrolysis (using pepsin, trypsin, 
chymotrypsin, and/or other proteases) resulted in 
high levels of ACE inhibition (73 % - 90 %). Pan et 
al. (2012) identify a novel angiotensin I-converting 
enzyme (ACE) inhibitory peptide from whey protein 
hydrolysed by trypsin. The amino acid sequence of 
the peptide with the greatest ACE inhibitory char-
acteristics was Leu-Leu (LL). 
The increased production of reactive oxygen 
species (ROS) and reactive nitrogen species, com-
bined with overtaking endogenous antioxidant de-
fence mechanisms so called oxidative stress is a 
significant factor for the initiation or progression of 
lifestyle related diseases. Consumption of antioxi-
dants appears to benefit endogenous antioxidant 
defence strategies in the fight against oxidative 
stress (Fang et al., 2002). Studies have shown 
that peptides with antioxidant properties can be 
released from milk proteins (Pihlanto, 2006). The 
use of synthetic antioxidants, such as butylated 
hydroxytoluene, butylated hydroxyanisole, propyl 
gallate, and tert-butylhydroquinone, has been re-
stricted because of their potential toxic effects on 
humans. On the other hand, bioactive peptides are 
considered natural antioxidants and have attracted 
a great deal of interest because of their safety and 
availability from a wide range of protein sources 
(Brandel l i  et al., 2015). Contributing to the antiox-
idant properties is also attributable to amino acids 
with aromatic residues that can donate protons to 
electron-deficient radicals. This property improves 
the radical-scavenging properties of the amino 
acid residues.
Diabetes is a serious chronic disease that oc-
curs either when the pancreas does not produce 
enough insulin (a hormone that regulates blood 
sugar, or glucose), or when the body cannot effec-
tively use the insulin it produces. Diabetes is one 
of the four no communicable diseases targeted for 
action by global researchers. Over the years, the 
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prevalence of diabetes has been progressively in-
creasing. According to the International Diabetes 
Federation (IDF, 2017), 425 million adults were liv-
ing with diabetes in 2017, compared to 250 mil-
lion in 2007. The global prevalence (age-standard-
ized) of diabetes has nearly doubled in 10 years. 
Diabetes complications can lead to heart attack, 
stroke, blindness, kidney failure, and lower limb 
amputation (Korhonen, 2009). Consumption of 
milk protein-derived bioactive peptides has been 
linked with serum glucose regulatory properties in 
humans. Different mechanisms may include an in-
sulinotropic activity, in cretin secretory actions, as 
well as the influence on activities of different met-
abolic enzymes involved in the regulation of serum 
glucose such as dipeptidyl peptidase IV (DPP-IV), 
α-amylase, and α-glucosidase (Parodi , 2016; Lac-
roix and Li-Chan, 2014). 
Furthermore, milk is a rich source of antimi-
crobial proteins and peptides, capable of exerting 
antimicrobial activities comparable to antibiotics. 
This effect is due to the synergistic activity of natu-
rally occurring peptides, immunmodulatory proteins 
such as lactoferrin, lactoperoxidase, and lysozyme, 
and is greater than any individual contribution 
(Clare et al., 2003). The most studied ones are the 
lactoferricins, derived from bovine and human Lf 
(Kitts and Weiler , 2003). Also, a few negatively 
charged peptides derived from β-Lg (Pel legrini et 
al., 2001) and α-La showed antibacterial activity 
against Gram-positive bacteria and a weak activ-
ity against Gram-negative bacteria. The disruption 
of normal membrane permeability is at least part-
ly responsible for the antibacterial mechanism of 
lactoferricins. The difference in net charge, charge 
distribution, size, amino acid sequence, and sec-
ondary structure along with amphipathicity might 
be responsible for the differential behaviour of the 
identified antibacterial peptides against bacteria 
(Brandel l i  et al., 2015). 
Another property that bioactive peptides exert 
is opioid activity. Opioid peptides are those pep-
tides that possess pharmacological similarities 
to opium, apropos pain relief. Opioid peptide se-
quences typically contain Tyr-Gly-Gly-Phe at their 
N-terminal side, and in the case of atypical opioid 
peptides, a Tyr residue is found at the N-terminus. 
These peptides have been reported to behave like 
morphine in the brain. These have been found with-
in milk proteins, both in casein (αs1-, αs2-, β-, and 
κ-) (casomorphins) and whey proteins (lactorphins). 
However, the major opioid peptides are fragments 
of β-casein, called β-casomorphins (Clare and 
Swaisgood, 2000). All κ-casein fragments, known 
as casoxins behave as opioid antagonists (Sever-
in and Wenshui , 2005). Opioid peptides have also 
been found encrypted within the primary sequence 
of whey proteins such as Lf, β-Lg, and bovine se-
rum albumin (Mann et al., 2019).
Bioactive lipids
Generally, lipids from milk fat possess a broad 
range of biological functions, and they have role 
in energy storage, intracellular signalling, thermo-
genesis, and structural integrity. Lipids also play 
an important role in pathology and prevention of 
numerous diseases like cardiovascular, neurological 
diseases, obesity, and metabolic syndrome, such as 
obesity and thus lipids have appeared as a compo-
nent of nutraceutical products. Lipids as nutraceu-
ticals are safe and have a potential therapeutic and 
health benefits, which may influence the outcome 
of many debilitating diseases (Kumar et al., 2018). 
Bovine milk fat is composed of more than 400 fat-
ty acids with different chemical composition. Most 
of these fatty acids are esterified to the glycerol 
molecule backbone and appear in milk fat mostly 
as triacylglycerols (Jensen, 2002; Gantner et al., 
2015). Conjugated linoleic acid (CLA) is a positional 
and geometrical isomer of cis - 9, cis - 12 - octa-
decadienoic acid (C18:2) with a conjugated double 
bond system. The major CLA isomer in milk fat is 
9 - cis, 11 - trans, also called rumenic acid (Butler 
et al., 2009; Col lomb et al., 2006). CLA is formed 
partially by bioconversion of polyunsaturated fat-
ty acids in the rumen by anaerobic bacteria, e.g., 
Butyrovibrio fibrisolvens, and primarily endogenously 
by desaturation of vaccenic acid in the mamma-
ry gland of lactating cows (Gri inari et al., 2000). 
Milk fat is the richest natural source of CLA with 
contents ranging from 2 to 53.7 mg g-1 fat that 
have been recorded in different studies (Col lomb 
et al., 2006). The wide range of CLA values can be 
attributed to various factors such as the feeding 
regime, forage preservation, geographical regions, 
and breed of cows as well as goats and sheep. Also, 
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some studies have demonstrated that pasture feed-
ing can significantly increase CLA concentrations as 
compared to indoor feeding. The grass composition 
of pasture seems to affect the CLA level because it 
was found to be almost 2-3 times higher in the milk 
of cows grazed in the alpine region as compared to 
milk from cows grazed in the lowlands (Col lomb et 
al., 2001). Experimental studies have demonstrated 
that feeding cows with meals containing plant oils 
and/or marine oils can effectively increase the CLA 
content. Also, it has been proven that concentrates 
rich in linoleic acid (rapeseed, soybean, sunflower) 
have a better impact than other polyunsaturated 
plant oils (peanut, linseed), whereas the dietary fish 
oils and their combination with plant oils appear 
even more effective than plant oils alone (Korho-
nen, 2009; Roy et al., 2006; Shingfield et al., 
2006). Another biologically active lipid group in milk 
fat are the polar lipids, which are mainly located in 
the milk fat globule membrane (MFGM). Milk fat 
membrane globule is a highly complex biological 
structure that surrounds the fat globule stabilizing 
it in the continuous aqueous phase of milk and pre-
venting it from enzymatic degradation by lipases 
(Mather, 2000; Spitsberg, 2005; Kamau et al., 
2010). The membrane consists of about 60 % pro-
teins and 40 % lipids that are mainly composed of 
triglycerides, cholesterol, phospholipids, and sphin-
golipids. The polar lipid content of raw milk ranges 
between 9.4 and 35.5 mg per 100 g of milk. The 
major phospholipid fractions are phosphatidyleth-
anolamine and phosphatidylcholine followed by 
smaller amounts of phosphatidylserine and phos-
phatidylinositol. The major sphingolipid fraction is 
sphingomyelin with smaller portions of ceramides 
and gangliosides. During milk processing into dif-
ferent dairy products, the polar lipids are preferen-
tially enriched in the aqueous phases like skimmed 
milk, buttermilk and butter serum (Kumar et al., 
2018). There are lot of researches that examine 
influence of MFGM on human health. Group of au-
thors Li et al. (2018) showed that MFGM improved 
the gut microbiota dysbiosis induced by high-fat 
diet in mice. Also, they indicated that there was 
a correlation between gut microbiota and obesi-
ty-related indexes. MFGM also alleviated high-fat 
diet-induced intestinal inflammation by decreasing 
the levels of interleukin-6 (IL-6), tumor necrosis 
factor-α (TNF-α), toll-like receptor 4 (TLR4) and in-
creasing the expression of tight junction proteins 
including zonulin-1 (ZO-1) and occludin. Moreover, 
MFGM significantly decreased the levels of lipopol-
ysaccharides (LPS), IL-6 and TNF-α in serum of 
high-fat diet-induced mice. Findings from Li et al. 
(2018) demonstrated that MFGM supplementation 
ameliorated obesity-related inflammation and en-
dotoxemia partly via modulating the composition 
of gut microbiota in mice challenged with a high-
fat diet. Furthermore, Castro-Gomez et al. (2016) 
evaluated antiproliferative effectiveness of lipid ex-
tracts and their neutral and polar fractions on nine 
human cancer cell lines. They concluded that these 
fractions, rich in phospho- and sphingolipids, were 
strongly antiproliferative against human ovary and 
colon cancer cells (Castro-Gomez et al., 2016). 
The richest source of milk fat membrane globule is 
buttermilk, which is unfortunately neglected. How-
ever, buttermilk should be aimed at promoting its 
use of polar lipid fractions as functional food ad-
ditives.
Growth factors
The presence of growth factors, either promot-
ing or growth or inhibitory activity for different cell 
types was first demonstrated in human colostrum 
and milk (Pouliot and Gauthier , 2006). Until now, 
growth factors that have been identified in milk are 
the beta cellulin (BTC), the epidermal growth factor 
(EGF), the fibroblast growth factor 1 and 2 (FGF1 
and FGF2), the insulin like growth factor I and II 
(IGF-I and IGF-II), the transforming growth factor 
β1 and β2 (TGF-β1 and TGF-β2) and the platelet 
- derived growth factor (PDGF). Available litera-
ture quotes that concentrations of the mentioned 
growth factors in bovine milk were the highest in 
colostrum during the first hours after calving and 
afterwards decrease substantially. The most abun-
dant growth factors in bovine milk are the EGF in 
a concentration from 2 to155 ng mL-1 followed by 
the IGF-I in a concentration from 2 to101 ng mL-1 
and the IGF-II in a concentration from 2 to 107 ng 
mL-1. Further growth factors that are also abundant 
in bovine milk are the TGF-β2 in a concentration 
from 13 to 71 ng mL-1, whereas the concentrations 
of the other known growth factors remain below 
4 ng mL-1 (Pouliot and Gauthier , 2006). Gener-
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ally, the growth factors are polypeptides and their 
molecular masses range between 6 to 30 kDa with 
amino acid residues varying from 53 (EFG) to about 
425 (TGF-β2), respectively. Some authors who have 
been researching influence of growth factors on 
thermal treatment concluded that growth factors 
are relatively well resistant to pasteurization and 
even to UHT (ultrahigh temperature) heat treat-
ment (Gauthier et al., 2006). The main biological 
functions of the milk growth factors have been 
reviewed by Gauthier et al. (2006) as well as by 
Tripathi and Vashishtha (2006). EGF and BTC 
stimulate the proliferation of epidermal, epithelial, 
and embryonic cells. They also inhibit the secretion 
of gastric acid and promote wound healing and 
bone resorption. Growth factors from the TGF-β 
family play an important role in the development 
of the embryo, tissue repair, formation of bone and 
cartilage, and regulation of the immune system. In 
addition, both forms of TGF-β are known to stimu-
late the proliferation of connective tissue cells and 
inhibit proliferation of lymphocytes and epithelial 
cells. Also, both forms of IGF stimulate proliferation 
of many cell types and regulate some metabolic 
functions, e.g., glucose uptake and synthesis of gly-
cogen (Pouliot and Gauthier , 2006).
Novel bioactive component  
from milk
It is well known that human milk is the best, 
complete and only food that is necessary for nor-
mal growth and development of infants until six 
months of their life. There is a question that can 
be asked, how is it possible that since today is not 
produced infant formula that can substitute human 
milk with all of its biological functions? This ques-
tion implies for itself that there are some gaps in 
detailed knowledge about the understanding and 
as well knowing the exact composition of milk. Re-
cently, group of scientists (Rani et al., 2017) estab-
lished the presence of bioactive component from 
milk, miRNA (microRNA). The presence of miRNAs 
has been established in almost every biological flu-
id. miRNAs are a class of small non-coding RNAs 
which are involved in regulation of gene expres-
sion. miRNAs approximately have 22 nucleotides 
in length and they were discovered for the first 
time in Caenorhabditis elegans (Lee et al., 1993). 
miRNAs are involved in different processes like de-
velopment, proliferation, immunity, apoptosis and 
much more (Bushati and Cohen, 2007). By apply-
ing bioinformatics methods it has been predicted 
that miRNAs most probably regulates 30 % of the 
protein coding genes in mammals. Milk as well as 
other biological fluids contains miRNAs, which are 
called the “Milk miRNAs”. Milk miRNAs have been 
isolated from different fractions from milk like lipid 
fraction, exosomal fractions or from whey fraction 
(Rani et al., 2017). For isolation of miRNA differ-
ent methods have been used like the Trizol LS ex-
traction, the miRNeasy kit, the mir-Vana miRNA 
isolation kit and the quantitative RT-PCR, which 
are the most frequently, used ones (Lekchnov et 
al., 2016). miRNA shows a specific stability when 
present in milk, and its main and most important 
property is the resistance to unfavourable environ-
mental conditions such as boiling, low pH, freezing 
or thawing up. The reason for such stability in the 
extreme environmental conditions is most probably 
the protective role of a lipid bilayer that is covering 
miRNAs (Baddela et al., 2016). Since miRNAs is 
resistant to low pH, it can easily pass through the 
gastrointestinal tract without degradation and thus 
it can affect the processes in the body. Expression 
of milk miRNA is variable during different stages 
of lactation. Colostrum contains higher amounts of 
miRNA than milk. Besides having a biological func-
tion, quantities of miRNA can be used for detection 
of milk adulteration. Group of scientists (Chen et 
al., 2010) identified 245 miRNAs in milk and they 
selected seven of those (miR-26a, miR-26b, 
miR-200c, miR-21, miR-30d, miR-99a, and miR-
148a) which are stable across the whole lacta-
tion. If milk is adulterated by dilution, levels of 
miRNAs drop significantly compared to the raw 
milk and thus, miRNAs presents a potential and 
the most precise biomarker in the dairy industry 
for detection of adulterated milk. miRNAs have 
been involved in an immune related processes by 
regulation of the immune cells like development, 
homeostasis, proliferation, differentiation, mi-
gration, communication and others. miRNAs are 
post-transcriptional regulators that can control 
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almost all the aspects of the immune cell behav-
iour. Since 245 miRNAs are identified from milk, 
their biological functions have not been inves-
tigated yet. Some miRNAs are well researched 
like the miR-27b that has a positive effect on 
immunosuppressive activity by inhibition of 
T-cell proliferation. In addition, miR-27b can 
modulate the immune responses and thus pre-
sents an oxidative stress responsive miRNA. Fur-
thermore, miR-106b inhibit by targeting auto-
phagy related genes and consequently combats 
against intracellular bacterial infections. miR-24 
significantly represses phagocytotic processes 
and associated inflammatory cytokines in cells. 
Most of miRNAs are involved in immune-stimu-
lating processes (Rani et al., 2017) and thus play 
an important role in the human health. 
Future perspective
Bioactive components, especially those derived 
from milk, belong to the most researched field over 
the past decade. Dairy industry has a leading role 
in creating the products that possess beneficial im-
pacts to human health. ACE inhibitory properties 
of casein or whey proteins hydrolysates have been 
proven in vivo and in vitro and are commercially 
available via various functional dairy products such 
as fermented milks or cheese. Future perspective in 
this area might be achieved by the use of predictive 
models and technological developments in large-
scale continuous production and isolation of bioac-
tive peptides. In addition, there is a lack of research 
focused on studying interactions between bioactive 
components and other food components during pro-
cessing, so there is a great need to explore those. 
Generally, milk- and milk products- derived bioactive 
components are safe for human use and they can be 
regarded as highly valuable ingredients for inclusion 
in a healthy lifestyle owing to their ability to prevent 
or reduce diseases such as stress, cardiovascular 
diseases, obesity and others. Bioactive milk compo-
nents possess a high potential for enhancing various 
biological functions in the human body resulting in a 
positive impact on the human health, and might re-
place conventional pharmaceutical therapy in future. 
Thus, by consuming food with declared bioactive 
components the consumers not only take food but 
are also taking care for health and at the same time, 
with the terminal outcome of preventing or even cur-
ing some diseases.
Bioaktivni sastojci kravljeg mlijeka
Sažetak
Funkcionalna hrana i bioaktivni sastojci hrane posljednjih su godina privukli veliku pažnju i zanimanje 
znanstvenika, nutricionista, zdravstvenih djelatnika te samih potrošača. Samo saznanje o funkcionalnoj 
hrani uvelike je olakšano napretkom znanosti te spoznajama o metaboličkim i genomskim utjecajem na 
prehranu te utjecajem određenih sastojaka hrane na ljudsko zdravlje. Poveznica zdravlja i prehrane je 
dobro poznata i glavni je ključ za prevenciju mnogih bolesti. Mlijeko se smatra izuzetno dobrim izvorom 
bioaktivnih sastojaka, a odavno je poznato da je namirnica s dobrim sastavom makro- i mikronutrije-
nata. Osim što se bioaktivni sastojci mlijeka prirodno nalaze u mlijeku i mliječnim proizvodima, oni se 
iz istih izoliraju te se koriste kao bioaktivni sastojci za proizvodnju funkcionalne hrane ili pak u farma-
ceutskoj industriji. Bioaktivni sastojci mlijeka imaju zaštitnu ulogu, kod novorođenčadi i odraslih, protiv 
patogena i bolesti. Glavni bioaktivni funkcionalni sastojci mlijeka nastaju iz kazeina, proteina sirutke, 
mliječne masti, laktoferina, vitamina, imunoglobulina i faktora rasta. Stoga je cilj rada bio dati pregled 
poznatih i onih tek nedavno detektiranih bioaktivnih sastojaka mlijeka te njihov utjecaj na zdravlje 
čovjeka. 
Ključne riječi: bioaktivni sastojci, mlijeko, bioaktivni peptidi, bioaktivni lipidi
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